Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 12, 2010, Pages 1367-1375

  Lockstone, Helen E ^a   Sanderson, Sharon ^b   Kulakova, Nina ^b   Baban, Dilair ^a   Leonard, Andrew ^c   Kok, Wai Ling ^b   McGowan, Simon ^b   McMichael, Andrew J ^b   Ho, Ling Pei ^b,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c East Sussex Healthcare NHS Trust   (United Kingdom)

^d OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Gene expression profiling; Lungs; Sarcoidosis

Indexed keywords

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBROSING ALVEOLITIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SET ENRICHMENT ANALYSIS; GENETIC ANALYSIS; GRANULOMATOSIS; HOST RESISTANCE; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG FIBROSIS; LUNG GRANULOMA; LUNG SARCOIDOSIS; MALE; MICROARRAY ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY; TREATMENT OUTCOME; BIOPSY; BRONCHUS; FIBROBLAST; GENETICS; LUNG; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOIDOSIS; UPREGULATION;

ADULT; AGED; BIOPSY; BRONCHI; DISEASE PROGRESSION; FEMALE; FIBROBLASTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LUNG; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOIDOSIS, PULMONARY; UP-REGULATION;

EID: 77954474075     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200912-1855OC     Document Type: Article

References (31)

1. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885-1889. (Pubitemid 33152325)
2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-2165.
3. Gerke AK, Hunninghake G. The immunology of sarcoidosis. Clin Chest Med 2008;29:379-390.
4. Hofmann S, Franke A, Fischer A, Jacobs G, Nothnagel M, Gaede KI, Schürmann M, Müller-Quernheim J, Krawczak M, Rosenstiel P, et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 2008;40:1103-1106.
5. Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A, Nagy M, Gaede KI, Franke A, Haesler R, Koch A, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005;37:357-364.
6. Nguyen T, Liu XK, Zhang Y, Dong C. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J Immunol 2006;176:7354-7360.
7. Moss S, Morgan R. The annexins. Genome Biol 2004;5:219-227.
8. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983;52:525-533. (Pubitemid 14245588)
9. Romer FK. Presentation of sarcoidosis and outcome of pulmonary changes. Dan Med Bull 1982;29:27-32.
10. Hillerdal GE, Nou K, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15 year European study. Am Rev Respir Dis 1984;130:29-32.
11. Sanderson S, Kulakova N, Lockstone H, Baban D, McMichael AJ, Ho LP. Gene-set analysis of lung samples from progressive, fibrotic pulmonary sarcoidosis shows pattern similar to hypersensitivity pneumonitis. Thorax 2009;64:A5-A74.
12. Morell F, Levy G, Orriols R, Ferrer J, De Gracia J, Sampol G. Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosis. Chest 2002;121:1239-1244.
13. Selroos O, Nikinmaa B, Koivunen E, Riska H, Tiitinen H, Weber T. Cellular immunity during follow-up of patients with sarcoidosis of varying duration. Clin Exp Immunol 1982;50:25-33.
14. Johns CJ, Scott PP, Schonfeld SA. Sarcoidosis. Annu Rev Med 1989;40:353-371.
15. Selman M, Pardo A, Barrera L, Estrada A, Watson SR, Wilson K, Aziz N, Kaminski N, Zlotnik A. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006;173:188-198. (Pubitemid 43187891)
16. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:1-28 (Article 3).
17. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80:1-16.
18. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003;19:368-375.
19. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003;34:374-378.
20. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene-set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545-15550.
21. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstråle M, Laurila E. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:244-245.
22. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45:2002-2008.
23. Oshita F, Ikehara M, Sekiyama A, Hamanaka N, Saito H, Yamada K, Noda K, Kameda Y, Miyagi Y. et al. Genome-wide cDNA microarray screening of genes related to benefits and toxicities of platinum-based chemotherapy in patients with advanced lung cancer. Am J Clin Oncol 2005;28:367-370.
24. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25-29.
25. Lovering RC, Camon EB, Blake JA, Diehl AD. Access to immunology through the Gene Ontology. Immunology 2008;125:154-160.
26. Simon R. Challenges of microarray data and the evaluation of gene expression profile signatures. Cancer Invest 2008;26:327-332. (Pubitemid 351601389)
27. Agostini C, Trentin L, Facco M, Semenzato G. New aspects of hypersensitivity pneumonitis. Curr Opin Pulm Med 2004;10:378-382.
28. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199-221.
29. Wells AU, Hogaboam CM. Update in diffuse parenchymal lung disease. Am J Respir Crit Care Med 2008;177:580-584.
30. Noble PW. Idiopathic pulmonary fibrosis: natural history and prognosis. Clin Chest Med 2006;27:S11-S16.(v.).
31. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-1181.